Welcome to LookChem.com Sign In|Join Free

CAS

  • or

261715-71-3

Post Buying Request

261715-71-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

261715-71-3 Usage

Description

3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID, also known as N-BOC-1-pyrrolidineacetic acid, is a chemical compound widely utilized in organic synthesis and pharmaceutical research. It features a BOC (tert-butoxycarbonyl) protective group, which endows it with versatility as an intermediate for the synthesis of a range of compounds. 3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID plays a significant role in the preparation of peptide nucleic acid (PNA) monomers, which are crucial for the development of innovative nucleic acid analogs. Furthermore, 3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID is instrumental in the synthesis of pharmaceutical compounds and the advancement of new drug formulations, making it an invaluable asset in medicinal chemistry and drug discovery.

Uses

Used in Pharmaceutical Research and Development:
3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID is used as a key intermediate in the synthesis of pharmaceutical compounds for various therapeutic applications. Its BOC protective group facilitates the creation of complex molecular structures, enhancing the compound's potential for drug development.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID is employed as a versatile building block for the assembly of diverse organic molecules. Its protective group allows for selective reactions, enabling the synthesis of target compounds with high precision and yield.
Used in Peptide Nucleic Acid (PNA) Monomer Preparation:
3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID is used as a crucial component in the preparation of PNA monomers, which are vital for the development of novel nucleic acid analogs. These analogs have potential applications in gene regulation, molecular diagnostics, and therapeutics.
Used in Medicinal Chemistry:
In medicinal chemistry, 3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID is utilized as a valuable chemical tool for the design and synthesis of new drugs. Its protective group and synthetic versatility contribute to the discovery of innovative therapeutic agents with improved efficacy and selectivity.
Used in Drug Discovery:
3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID plays a significant role in drug discovery, where it is employed to explore new chemical entities with potential therapeutic benefits. Its unique properties and synthetic capabilities aid in the identification and optimization of lead compounds for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 261715-71-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,7,1 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 261715-71:
(8*2)+(7*6)+(6*1)+(5*7)+(4*1)+(3*5)+(2*7)+(1*1)=133
133 % 10 = 3
So 261715-71-3 is a valid CAS Registry Number.

261715-71-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name [3-(N-tert-butoxycarbonyl)aminopyrrolidin-1-yl]acetic acid

1.2 Other means of identification

Product number -
Other names 2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrolidin-1-yl]acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:261715-71-3 SDS

261715-71-3Downstream Products

261715-71-3Relevant articles and documents

α-substituted n-(sulfonamido)alkyl-β-aminotetralins: Potent and selective neuropeptide Y Y5 receptor antagonists [2]

Youngman, Mark A.,McNally, James J.,Lovenberg, Timothy W.,Reitz, Allen B.,Willard, Nicole M.,Nepomuceno, Diane H.,Wilson, Sandy J.,Crooke, Jeffrey J.,Rosenthal, Daniel,Vaidya, Anil H.,Dax, Scott L.

, p. 346 - 350 (2007/10/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 261715-71-3